Pharmacotherapy for Obesity | July 2021-Presentation

Presentation

Pdf Summary

This presentation discusses weight loss pharmacotherapy and various medications used for weight management. The speaker first discusses the medical history of patients that could benefit from weight loss interventions. They then provide ground rules for weight loss pharmacotherapy, emphasizing the importance of evaluating co-indications and considering factors such as cost, side effects, and patient preference. The speaker also highlights the need for at least 5% weight loss in 3-6 months for insurance purposes.<br /><br />The presentation then delves into medications causing weight gain, including steroids, mental health medications, diabetes medications, antiepileptics, beta-blockers, contraceptives, and antihistamines. The potential impact of these medications on weight gain is discussed.<br /><br />Next, the presentation focuses on specific medications used for weight management, including phentermine, topiramate, buproprion/naltrexone, zonisamide, orlistat, and GLP-1 receptor agonists such as semaglutide and liraglutide. The mechanisms, dosing, co-indications, side effects, contraindications, and efficacy of each medication are discussed.<br /><br />The presentation concludes with a brief overview of metformin and SGLT-2 inhibitors, and the potential benefits of these medications in weight management. The speaker also highlights the importance of considering comorbidities such as diabetes and cardiovascular disease in weight management approaches.<br /><br />Overall, the presentation provides a comprehensive understanding of various medications used for weight management and their potential benefits and considerations.

Keywords

weight loss pharmacotherapy

medications

weight management

medical history

co-indications

side effects

insurance purposes

medications causing weight gain

specific medications

comorbidities